FENNEC PHARMACEUTICALS ($FENC) posted quarterly earnings results for Q3 2026 on Thursday, November 12th. The company reported earnings of $0.12 per share, beating estimates of $0.09 by $0.03. The company also reported revenue of $19,610,000, beating estimates of $19,189,943 by $420,057.
You can see Quiver Quantitative's $FENC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
FENNEC PHARMACEUTICALS Insider Trading Activity
FENNEC PHARMACEUTICALS insiders have traded $FENC stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $FENC stock by insiders over the last 6 months:
- ROBERT ANDRADE (CHIEF FINANCIAL OFFICER) sold 75,000 shares for an estimated $883,500
- MARCO MARIA BRUGHERA sold 15,545 shares for an estimated $159,958
- PIERRE SARGIS SAYAD (Chief Medical Officer) sold 12,000 shares for an estimated $146,160
- ROSTY RAYKOV sold 10,000 shares for an estimated $121,100
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
FENNEC PHARMACEUTICALS Hedge Fund Activity
We have seen 61 institutional investors add shares of FENNEC PHARMACEUTICALS stock to their portfolio, and 33 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOUTHPOINT CAPITAL ADVISORS LP removed 2,744,741 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $29,505,965
- SOLAS CAPITAL MANAGEMENT, LLC removed 592,832 shares (-23.9%) from their portfolio in Q2 2026, for an estimated $6,372,944
- PROSPECT CAPITAL ADVISORS, LLC added 497,800 shares (+inf%) to their portfolio in Q2 2026, for an estimated $5,351,350
- AWM INVESTMENT COMPANY, INC. added 440,161 shares (+61.1%) to their portfolio in Q2 2026, for an estimated $4,731,730
- BLACKROCK, INC. added 358,893 shares (+26.2%) to their portfolio in Q2 2026, for an estimated $3,858,099
- ESSEX INVESTMENT MANAGEMENT CO LLC added 318,771 shares (+inf%) to their portfolio in Q3 2026, for an estimated $3,394,911
- ROSALIND ADVISORS, INC. added 279,800 shares (+9.6%) to their portfolio in Q2 2026, for an estimated $3,007,850
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
